Eli Lilly Ceo Our Pill

Media Summary: The increasing popularity of GLP-1 weight-loss drugs has driven drugmaker Jan.09 -- David Ricks, chairman and chief

Eli Lilly Ceo Our Pill - Detailed Analysis & Overview

The increasing popularity of GLP-1 weight-loss drugs has driven drugmaker Jan.09 -- David Ricks, chairman and chief

Photo Gallery

Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine

Eli Lilly CEO: Our pill supply can 'reach the planet'

Eli Lilly Is Working on an Anti-Obesity Pill, Says CEO Dave Ricks

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing

Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

Eli Lilly CEO on Drug Pricing and Diabetes Treatment

Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

Eli Lilly CEO David Ricks on Q1 results, weight loss drug competition and status of weight-loss pill

Eli Lilly CEO: We see a path to an Alzheimer's disease-modifying drug

Eli Lilly CEO on Fighting Obesity, Developing New Drugs

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Eli Lilly CEO David Ricks on 3-year obesity drug study: This is a profound result

View Detailed Profile

Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine

Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine

The increasing popularity of GLP-1 weight-loss drugs has driven drugmaker

Eli Lilly CEO: Our pill supply can 'reach the planet'

Eli Lilly CEO: Our pill supply can 'reach the planet'

Eli Lilly

Eli Lilly Is Working on an Anti-Obesity Pill, Says CEO Dave Ricks

Eli Lilly Is Working on an Anti-Obesity Pill, Says CEO Dave Ricks

Eli Lilly

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing

Eli Lilly

Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

Eli Lilly CEO

Eli Lilly CEO on Drug Pricing and Diabetes Treatment

Eli Lilly CEO on Drug Pricing and Diabetes Treatment

Jan.09 -- David Ricks, chairman and chief

Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

Eli Lilly CEO

Eli Lilly CEO David Ricks on Q1 results, weight loss drug competition and status of weight-loss pill

Eli Lilly CEO David Ricks on Q1 results, weight loss drug competition and status of weight-loss pill

Eli Lilly

Eli Lilly CEO: We see a path to an Alzheimer's disease-modifying drug

Eli Lilly CEO: We see a path to an Alzheimer's disease-modifying drug

Eli Lilly CEO

Eli Lilly CEO on Fighting Obesity, Developing New Drugs

Eli Lilly CEO on Fighting Obesity, Developing New Drugs

Eli Lilly

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

(0:00) Introducing

Eli Lilly CEO David Ricks on 3-year obesity drug study: This is a profound result

Eli Lilly CEO David Ricks on 3-year obesity drug study: This is a profound result

CNBC's Angelica Peebles and

Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma

Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma

Dave Ricks, the